Stories by STAT

Phage therapy is not approved for regular use by the FDA

Tom Price has opposed abortion rights and embryonic stem cell research funding

Funding for the act, which aims to speed approval of new drugs and devices, may be in jeopardy

The result could be a major setback for the strategy of attacking amyloid plaques 

The drop suggests certain actions may reduce disease risk

There are tantalizing hints that women respond differently to concussion, perhaps due to hormonal cycles. What's needed now: more female brains to study

Physicians are hired and fired by the team, not the athletes

The disease threat still remains an enduring challenge

Priorities at the NIH, the BRAIN Initiative, drug price controls and more initiatives could shift in major ways

The new president-elect will have to consider how to drive down health costs 

The vote was nonbinding and now moves to a five-person board 

The drug-resistant fungus is often fatal and can be difficult to identify

Critics say the practice, which may lead to possible racial bias, has outpaced the science

Weeks after infection mice had shrunken testicles and lower levels of sex hormones

The fruity with a hint of double helix assertion is not backed by strong science

Wolbachia-laden bugs will be deployed in two South American cities

The massive editing project only took months to complete 

Previous recommendations suggested limiting exposure to two hours a day for older children

After decades of disappointment there is a new flurry of vaccine activity 

Several start-ups are searching for fresh insights before couples turn to in vitro fertilization

The warning from the CDC comes after at least 11 people were sickened

Discovery sparks questions about factors that may make ailment harder to cure or lead to misdiagnosis

As the first T-cell therapies for tumors near U.S. approval, researchers race to engineer less-toxic alternatives 

The results are the first from a randomized, controlled trial of the treatment